Direvo Reaches Milestone in Consolidated Bioprocessing of Lignocellulose to Lactic Acid
News Mar 12, 2013
Direvo Industrial Biotechnology GmbH (Direvo) has announced that it has reached an important milestone in developing a consolidated bioprocess for lactic acid production from lignocellulose.
Up until now, there has not been any known consolidated bioprocess for producing lactic acid from lignocellulose.
Direvo has now successfully built up a processing chain from pretreatment through fermentation to downstream processing for a consolidated bioprocess for lactic acid.
On the basis of pretreated Miscanthus grass, Direvo fermented lactic acid on pilot scale in a single-step-synthesis.
Direvo was further able to show that the important step of downstream processing of free lactic acid in the fermentation matrix can be realized efficiently by standardized procedures.
The downstream processing was executed in collaboration with the department of bioengineering of the Leibniz Institute for Agricultural Engineering Potsdam-Bornim.
Direvo’s specific, self-isolated proprietary microorganism Caldicellulosiruptor sp. produces the needed enzymes to ferment the pretreated biomass and converts the emerging sugar to end products.
In these processes, no cost-intensive technical enzymes have to be added.
A further advantage is that these microorganisms are extreme thermophile and therefore high process temperatures don’t cause product losses through contamination with foreign bacteria.
On the basis of this proof-of-concept, the next development stage to raise competitiveness in a commercial environment will be to increase the yield of lactic acid.
Consolidated bioprocessing is the conversion of lignocellulose into target products in a single step without having to add enzymes.
Direvo develops consolidated bioprocesses for production of biofuels and biobased chemicals under the brand name BluCon®.
Beside Lactic Acid, BluCon®-L, Direvo pursues with Ethanol, BluCon®-E, another product line.
BluCon® converts various non-food biomass ranging from grasses and straw to agricultural and wood residues and can therefore be applied around the globe.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018